Glazer Capital, Llc - 31 Mar 2025 SCHEDULE 13G/A Report for Revance Therapeutics, Inc. Common Stock, par value $0.001 per share (RVNC)

Filing Manager: Glazer Capital, Llc
Reporting Manager: Glazer Capital, LLC
Security: Revance Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol: RVNC
Disclosed Ownership: 0 shares
Ownership: 0%
Form type: SCHEDULE 13G/A
Filing time: 15 May 2025, 16:33:38
Date of event: 31 Mar 2025
Previous filing: 06 Feb 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Glazer Capital, LLC	0%	0	0	0	Paul J. Glazer	Paul J. Glazer, Managing Member
Paul J. Glazer	0%	0	0	0	Paul J. Glazer	Paul J. Glazer